skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

Effects of allopurinol and vitamin E on renal function in patients with cardiac coronary artery bypass grafts

Original Research

(3363) Views  (688) Full article downloads

Authors: Nader Nouri-Majalan, Ehsan Fotouhi Ardakani, Khalil Forouzannia, Hosein Moshtaghian

Published Date May 2009 Volume 2009:5 Pages 489 - 494
DOI: http://dx.doi.org/10.2147/VHRM.S5761

Nader Nouri-Majalan1, Ehsan Fotouhi Ardakani2, Khalil Forouzannia3, Hosein Moshtaghian4

1Department of Nephrology, 3Department of Cardiovascular Surgery, 4Department of Anesthesiology, Afshar Hospital, Shahid Sadoughi University of Medical Sciences, Yazd, Iran; 2Ali bin Abu Taleb Medical College, Yazd Azad University, Yazd, Iran

Background: Acute renal failure is a common complication of cardiac surgery, with oxidants found to play an important role in renal injury. We therefore assessed whether the supplemental antioxidant vitamin E and the inhibitor of xanthine oxidase allopurinol could prevent renal dysfunction after coronary artery bypass graft (CABG) surgery.

Methods: Of 60 patients with glomerular filtration rate (GFR) < 60 mL/min scheduled to undergo CABG surgery, 30 were randomized to treatment with vitamin E and allopurinol for 3–5 days before surgery and 30 to no treatment. Serum creatinine levels and potassium and creatinine clearances were measured preoperatively and daily until day 5 after surgery.

Results: The patients consisted of 31 males and 29 females, with a mean age of 63 ± 9 years. After surgery, there were no significant differences in mean serum creatinine (1.2 ± 0.33 vs 1.2 ± 0.4 mg/dL; p = 0.43) concentrations, or creatinine clearance (52 ± 12.8 vs 52 ± 12.8 mL/min; p = 0.9). The frequency of acute renal failure did not differ in treatment group compared with control (16% vs 13%; p = 0.5). Length of stay in the intensive care unit (ICU) was significantly longer in the control than in the treated group (3.9 ± 1.5 vs 2.6 ± 0.7 days; p < 0.001).

Conclusion: Prophylactic treatment with vitamin E and allopurinol had no renoprotective effects in patients with pre-existing renal failure undergoing CABG surgery. Treatment with these agents, however, reduces the duration of ICU stay.

Keywords: antioxidants, coronary artery bypass, prevention and control, renal function






 

Other articles by Dr Nader Nouri-Majalan



Readers of this article also read:

Arterial stiffness in insulin resistance: The role of nitric oxide and angiotensin II receptors
Risk factors associated with methamphetamine use and heart failure among Native Hawaiians and other Pacific Island peoples
Effect of losartan on Doppler sonography indices in kidney transplant patients: A randomized clinical trial
Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors
Anteroposterior diameter of the infrarenal abdominal aorta is higher in women with polycystic ovary syndrome
Bosentan in the treatment of pulmonary arterial hypertension with the focus on the mildly symptomatic patient
Comparison of prasugrel and clopidogrel in patients with acute coronary syndrome undergoing percutaneous coronary intervention
Early cardiovascular abnormalities in newly diagnosed obstructive sleep apnea
Hemocompatibility of stent materials: alterations in electrical parameters of erythrocyte membranes
Cardiac ryanodine receptor in metabolic syndrome: is JTV519 (K201) future therapy?
  • Join ISVH

    Be part of the World's leading experts in vascular health by joining the International Society of Vascular Health (ISVH)

  • Testimonials

    "... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University